BORKOWSKI EDWARD 4
4 · AzurRx BioPharma, Inc. · Filed Jun 1, 2020
Insider Transaction Report
Form 4
BORKOWSKI EDWARD
Director
Transactions
- Award
9.0% Senior Convertible Promissory Note
2020-06-01$100000.00/shExercise: $1.07From: 2019-12-20Exp: 2020-09-20→ Common Stock (93,458 underlying) - Disposition to Issuer
9.0% Senior Convertible Promissory Note
2020-06-01$100000.00/sh→ 0 totalExercise: $0.97From: 2019-12-20Exp: 2020-09-20→ Common Stock (103,093 underlying)
Footnotes (3)
- [F1]On June 1, 2020, AzurRx Biopharma, Inc. (the "Company") and Edward Borkowski amended the Senior Convertible Promissory Note (the "Note") previously issued on December 20, 2019 to increase the conversion price from $0.97 per share to $1.07 per share.
- [F2]Represents the number of shares of the Company's common stock, par value $0.001 per share ("Common Stock") issuable upon conversion of the principal amount of the Note at the original conversion price of $0.97 per share.
- [F3]Represents the number of shares of Common Stock issuable upon conversion of the principal amount of the Note at the amended conversion price of $1.07 per share.